Stylage® Hydro (1 x 1 ml)

STYLAGE

Aesthetic / Dermal Filler / Skin Booster

Hyaluronic acid mesotherapy injectable (hydration & skin revitalisation)

CE Marked medical device (as indicated in product listing for distribution in EU/UK aesthetics markets) according to distributor/manufacturer statements. :contentReference[oaicite:15]{index=15}

CE Marked medical device (as indicated in product listing for distribution in EU/UK aesthetics markets) according to distributor/manufacturer statements. :contentReference[oaicite:15]{index=15}

Hyaluronic acid mesotherapy injectable (hydration & skin revitalisation)

Description

STYLAGE Hydro is a non-crosslinked hyaluronic acid (HA) injectable gel with mannitol antioxidant, developed by Vivacy Laboratories for skin hydration and revitalisation. Supplied as a 1 ml pre-filled syringe for mesotherapy injections intended to improve skin hydration, elasticity and overall dermal quality on face, neck, décolleté and hands.

Bnefits

Restores skin hydration and combats dehydration
Improves skin elasticity, firmness, and suppleness
Provides skin revitalisation and a natural glow
Antioxidant (mannitol) helps protect HA from oxidative degradation and may reduce post-injection inflammation
Suitable for mild to moderate skin aging or environmental damage (dryness, laxity, dull skin)

Indications

Skin dehydration and loss of elasticity
Skin laxity, dull or aging skin needing rehydration and improved dermal quality
Revitalisation of face, neck, décolleté, and hands (skin booster applications)
Preventative and maintenance treatments for early signs of aging or dry skin

Composition

Non-crosslinked sodium hyaluronate (hyaluronic acid) — concentration ~14 mg/ml (some sources report 14 mg/g) :contentReference[oaicite:0]{index=0}
Mannitol (antioxidant) — to protect the HA and reduce oxidative degradation/reaction risk :contentReference[oaicite:1]{index=1}

Formulation

Sterile, single-use 1 ml pre-filled syringe containing non-crosslinked HA gel with mannitol (mesotherapy formulation for skin hydration rather than volumising) :contentReference[oaicite:2]{index=2}

Packaging

1 × 1 ml pre-filled syringe plus 2 sterile 30G needles (as commonly supplied by distributors) :contentReference[oaicite:3]{index=3}

Usage

Must be administered by qualified medical professionals experienced in aesthetic injectables.
Inject into superficial or mid-dermis (dermo-epidermal junction or superficial dermis) depending on skin condition and treatment area. Techniques include nappage or mesotherapy micro-injections with fine needles. :contentReference[oaicite:4]{index=4}
Recommended treatment protocol: 1–3 sessions within 3–4 weeks, then maintenance injections every 3–6 months depending on skin condition and patient factors. :contentReference[oaicite:5]{index=5}
Use aseptic technique for all injections; avoid inflamed or infected skin; follow standard post-injection care (e.g., avoid irritation, sun exposure, strenuous activity for a short period). :contentReference[oaicite:6]{index=6}

Contraindications

Hypersensitivity to hyaluronic acid, mannitol, or any other component of the product (as per product information) :contentReference[oaicite:9]{index=9}
Active skin infection, inflammation or lesions at the intended injection site :contentReference[oaicite:10]{index=10}
Pregnancy and breastfeeding (use not recommended in many filler/mesotherapy IFUs; standard caution advised) — distributors mention pregnancy/lactation as precaution. :contentReference[oaicite:11]{index=11}

Adverse Effects

Common, usually transient: redness, swelling, tenderness, bruising, itching or small papules at injection sites. :contentReference[oaicite:12]{index=12}
Uncommon/rare: risk of inflammation, infection; in case of improper injection, risk of skin irregularities or more serious complications (standard injectable risks) — professional administration and aseptic technique required. :contentReference[oaicite:13]{index=13}

Storage Conditions

Store at 2°C to 25°C; avoid freezing, excessive heat or direct sunlight; keep syringe sealed until use and observe expiry date as indicated by manufacturer/distributor packaging. :contentReference[oaicite:14]{index=14}

Duration

Typical interval for maintenance about every 3\u20136 months; individual results vary. :contentReference[oaicite:7]{index=7}

Onset

Improved skin hydration and appearance often visible shortly after injection (once initial redness/swelling subsides); cumulative improvement over course of sessions. :contentReference[oaicite:8]{index=8}